The U.S. FDA relied on a critically flawed risk-benefit assessment to authorize emergency use of Pfizer’s COVID-19 vaccine for children 5-11 years of age.
Robert Kennedy Jr. interviews Judy Wilyman on mandatory and coercive vaccination, the ethics of childhood vaccination and changes in vaccine surveillance.
The injection that got the FDA approval is a Pfizer/BioNTech, to be sold under the brand name Comirnaty, and this injection is not currently available.
